Arch Therapeutics, Inc.
United StatesFDA applicant, unverified
- Devices
- 4
What Arch Therapeutics, Inc. makes
Arch Therapeutics, Inc. manufactures AC5 Topical Gel, a dermatological formulation intended for topical skin application.
The company’s portfolio is regulated under FDA’s Class II (U) device classification and is listed via the 510(k) pathway. The company is based in the United States.
Catalogue
- Registry: GUDID
- Registry: GUDID
AC5 Topical Gel Ref K190129
Regimes: 510(k) Registry: 510(k)AC5 Topical Gel Ref K182681
Regimes: 510(k) Registry: 510(k)
Company details
- DUNS number
- 119045363
Frequently asked questions
How many devices does Arch Therapeutics, Inc. have in the registry?
The registry currently lists 4 devices for Arch Therapeutics, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Arch Therapeutics, Inc.'s devices?
Among its 4 most recently registered devices, Arch Therapeutics, Inc. has devices listed in FDA 510(k) (2 devices) and FDA GUDID (2 devices). A device can be listed in more than one registry, so these counts overlap.
What are the newest devices from Arch Therapeutics, Inc. in the registry?
The most recently registered devices listed for Arch Therapeutics, Inc. include VIA Linx AVX03001, AC5 Advanced Wound System AC5-1001 and AC5 Topical Gel.